dental specialties

4th Merck osteonecrosis trial begins

Merck will again “vigorously defend itself” against allegations that its Fosamax bisphosphonate drug caused dental and jaw-related problems in a jury trial that began January

Oasis Diagnostics to market dry mouth product

Amarillo Biosciences and Oasis Diagnostics have entered into an agreement for Oasis to exclusively market Maxisal, Amarillo Biosciences’ dietary supplement for enhancing salivary function, promoting

Deconstructing the arguments against BPA

The case against bisphenol A (BPA) as an estrogen-mimetic toxin is weakening, according to a presentation last week at the Rocky Mountain Dental Convention in

AAPHD applauds new fluoride recommendations

The American Association of Public Health Dentistry (AAPHD) supports the recent recommendation by the U.S. Department of Health and Human Services and the Environmental Protection

WhatsApp